United Kingdom over the
counter (OTC) drugs market is anticipated to register growth with an impressive
CAGR in the forecast period, 2023-2027. The market growth can be attributed to surging
demands for the cold & flu medicines. Higher prices of branded drugs along
with the growing prevalence of infectious diseases further drives the growth of
the United Kingdom over the country (OTC) drugs market in the upcoming five
years. Consistent research and advancement of the pharmaceutical industry
coupled with the local manufacturing of the generic drugs also supports the
growth of the United Kingdom over the counter (OTC) drugs market in the next
five years.
Over the counter (OTC) drugs
are the non-prescription based medicines that are usually sold without any
legal prescription and are often with no side effects. These drugs are safe and
do not have any addictive nature if consumed un-monitored or without
physicians’ prescription. Although, as a general awareness the physicians often
advise to consult doctors and experts regarding illness before self-prescribing
any kind of medicine. Basic cold medicines, vitamin tablets, or health
supplements are different categories of over the counter (OTC) drugs.
Expanding Pharmaceutical
Industry Promises Market Growth
Surge in the demand for
advanced medicine in affordable prices drive the growth of the United Kingdom
over the counter (OTC) drugs market in the upcoming five years. In 2019, the
annual turnover of pharmaceutical goods wholesalers in the UK was over USD63
billion. The pharmaceutical industry holds position among top 10 global
industries for pharmaceutical products that accounts for over 2.5% of the
global market. Imports of pharmaceutical products from other countries have
considerably decreased in 2020 valued at USD20,871 million from USD23,458
million in the year 2019. Decreased imports points to increased research and
development along with growing inclination of the consumers toward over the
counter (OTC) drugs, thereby substantially supporting the growth of the United
Kingdom over the counter (OTC) drugs market in the next five years.
Investments and Expenses
Drives Market
Growing investments and
rising expenses over the pharmaceutical products, and therapeutics in the
country further supports the growth of the United Kingdom over the counter (OTC)
drugs market in the future five years. Government is actively investing in the
pharmaceutical industry to promote the local manufacturers along with rising
expenditures by the consumers demanding for advanced & affordable
pharmaceutical products, thereby aiding the growth of the United Kingdom over
the counter (OTC) drugs market in the forecast years.
Click here to download the sample
Market Segmentation
The
United Kingdom over the counter (OTC) drugs market is segmented by product,
route of administration, dosage form, distribution channel, competitional
landscape, and regional distribution. Based on product, the market is further
segmented into cough, cold and flu; vitamins, mineral, and supplements (VMS);
analgesics; gastrointestinal products; dermatology products; and others. By
route of administration, the market is fragmented into oral, topical, and parenteral.
Based on dosage form, the market is differentiated into tablets, capsules,
liquids & solution, creams/lotions/ointments, and others. Based on
distribution channel, the market is bifurcated into retail pharmacy, hospital
pharmacy, and e-pharmacy. The market analysis also studies the regional
segmentation to devise regional market segmentation, divided among London, East
Anglia, Southwest, Southeast, Scotland, East Midlands, and Yorkshire &
Humberside.
Company Profile
GlaxoSmithKline Plc., Novartis UK
Limited, Sun Pharmaceuticals UK Limited, Johnson & Johnson Limited, Perrigo
Company Plc., Reckitt Benckiser Plc., AstraZeneca Plc., among others is a partial list of
major market players of the companies responsible for the growth of United
Kingdom over the counter (OTC) drugs market.
Attribute
|
Details
|
Base Year
|
2021
|
Historical Data
|
2017 – 2020
|
Estimated Year
|
2022
|
Forecast Period
|
2023 – 2027
|
Quantitative Units
|
Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027
|
Report coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
Segments covered
|
·
Product
·
Route of Administration
·
Dosage Form
·
Distribution Channel
|
Regional scope
|
London, East Anglia, Southwest, Southeast, Scotland, East
Midlands, and Yorkshire & Humberside
|
Key companies profiled
|
GlaxoSmithKline Plc., Novartis UK
Limited, Sun Pharmaceuticals UK Limited, Johnson & Johnson Limited,
Perrigo Company Plc., Reckitt Benckiser Plc., AstraZeneca Plc.
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
Pricing and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
Delivery Format
|
PDF and Excel through Email
(We can also provide the editable version of the report in PPT/Word format on
special request)
|
Report Scope:
In this report, United Kingdom over the counter (OTC) drugs market has been segmented into
following categories, in addition to the industry trends which have also been
detailed below:
- United Kingdom Over The Counter (OTC)
Drugs Market, By Product:
- Cough, Cold and Flu
- Vitamins, Mineral, and Supplements
(VMS)
- Analgesics
- Gastrointestinal Products
- Dermatology Products
- Others
- United Kingdom Over The Counter
(OTC) Drugs Market, By Route of Administration:
- United Kingdom Over The Counter (OTC)
Drugs Market, By Dosage Form:
- Tablets
- Capsules
- Liquids & Solution
- Creams/ Lotions/ Ointments
- Others
- United Kingdom Over The Counter (OTC)
Drugs Market, By Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- E-Pharmacy
- United Kingdom Over The Counter (OTC)
Drugs Market, By Region:
o London
o East Anglia
o Southwest
o Southeast
o Scotland
o East Midlands
o Yorkshire & Humberside
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in United Kingdom over the counter (OTC) drugs market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to
five).
United Kingdom Over the counter (OTC) drugs Market is an upcoming report
to be released soon. If you wish an early delivery of this report or want to
confirm the date of release, please contact us at [email protected]